Carl V. Hamby

Carl V. Hamby is an Associate Professor in the Department of Pathology, Microbiology and Immunology at New York Medical College’s School of Medicine. His research spans melanoma tumor biology, cardiology, and immunology, focusing on biological cytotoxins targeting tumors, stem cell therapies for heart disease, and immune mechanisms of bacterial compounds.

• Ph.D., University of Missouri-Columbia
• M.S., University of Missouri-Columbia

Dr. Hamby’s research explores three major areas:

• Tumor Biology: Developing biological cytotoxins targeting melanoma and tumor vasculature
• Cardiology: Investigating bone marrow stem cells in heart disease treatment
• Immunology: Studying immune mechanisms of oligoribonucleotides in tumor hosts

His recent publications (2009-2024) demonstrate expertise in

• Targeted cancer therapies
• Cardiovascular stem cell applications
• Molecular immunomodulation
• Biological toxin delivery systems
• Medical imaging of tumor receptors
• Immune mechanism exploration